ADDITIONAL SAFETY AND EFFICACY RESULTS FROM HELIOS: A PHASE 2, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA

Authors
Category Primary study
Conference31st Congress of the European Hematology Association Congress, EHA 2026
Year 2026
This article has no abstract
Epistemonikos ID: 96d687a0d345757d97866dbf5d798e628cd63f0f
First added on: Aug 08, 2026